Nathan D. Jorgensen - 01 Feb 2022 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Financial Officer
Signature
/s/ Nathan Jorgensen
Issuer symbol
VOR
Transactions as of
01 Feb 2022
Transactions value $
$0
Form type
4
Date filed
03 Feb 2022, 15:32
Next filing
06 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +135K $0.00 135K 01 Feb 2022 Common Stock 135K $8.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests over four years in equal monthly installments beginning on February 1, 2022.